JENNY ROHLIN: Open Payments
NPI 1609611656 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 22 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $100 |
| Gilead Sciences, Inc. | 4 | $81 |
| ABBVIE INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Insulet Corporation | 1 | $29 |
| Abbott Laboratories | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Wegovy, UBRELVY, SHINGRIX, OMNIPOD, FREESTYLE LIBRE 3, Veozah, MOUNJARO, VRAYLAR.
Industry payments across NY — which companies pay providers there.
